Most discussions of AI-generated code focus on whether AI can write code. The harder question is whether you can trust it.

Artificial intelligence is quickly becoming a defining question for software leaders. New tools appear weekly, demos promise ...

AI lets you code at warp speed, but without Agile "safety nets" like pair programming and automated tests, you're just ...

CINCINNATI, Ohio. (Ivanhoe Newswire) - Endometriosis is a painful and often debilitating disease that affects an estimated 6.5 million women in the U.S. It occurs when tissue similar to the lining of ...

Texas has clearly emerged as the leading U.S. testing ground for autonomous freight, with multiple companies now moving from pilot testing to approved, corridor-based, and even commercial driverless ...

The challenge is that, in many organizations, the CAE (computer-aided engineering) review process hasn’t kept pace with advances in simulation tools. As a result, a widening gap exists between running ...

Driven By Her Own Pain: First At-Home Test for Endometriosis: Imagine having pain so bad that your hands would shake and not getting a diagnosis for years. But someone is taking matters into her own ...

Addis Ababa, March 9, 2026 (ENA)—Prime Minister Abiy Ahmed has described a newly developed rural corridor village in Ethiopia’s Harari Region as a model for community-driven development. He ...

Dr. Son Nguyen is the cofounder & CEO of Neurond AI, a company providing world-class artificial intelligence and data science services. AI has made coding feel like magic with its ability to generate ...

Spec-driven development (SDD) offers a structured approach to AI-assisted coding by prioritizing detailed specifications before any code is written. Unlike “vibe coding,” which relies on iterative ...

With uninterrupted agent execution increasingly replacing interactive prompting, intent articulation becomes even more critical to using coding agents effectively. While Spec-Driven Development (SDD) ...

WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, the developer of the leading AI foundation model for tumor and immune biology, today announced a strategic collaboration with Daiichi Sankyo (TSE: 4568).